Number of the records: 1
Switch from biosimilar infliximab CT-P13 to biosimilar infliximab SB-2 in the long-term maintenance therapy in IBD patients – prospective observational study
SYS 0577160 LBL 01000a^^22220027750^450 005 20250220114601.6 014 $a 85174406531 $2 SCOPUS 017 $a 10.48095/ccgh2023336 $2 DOI 100 $a 20231027d m y slo 03 ba 101 $a eng 102 $a CZ 200 1-
$a Switch from biosimilar infliximab CT-P13 to biosimilar infliximab SB-2 in the long-term maintenance therapy in IBD patients – prospective observational study 215 $a 6 s. $c P 463 -1
$1 001 cav_un_epca*0384129 $1 011 $a 1804-7874 $1 200 1 $a Gastroenterologie a hepatologie $v Roč. 77, č. 4 (2023), s. 336-341 610 $a inflammatory bowel disease 610 $a biosimilar infliximab CT-P13 610 $a biosimilar infliximab SB-2 610 $a therapeutical switch 700 -1
$3 cav_un_auth*0078496 $a Lukáš $b M. $y CZ 701 -1
$3 cav_un_auth*0403037 $a Hrubá $b V. $y CZ 701 -1
$3 cav_un_auth*0100815 $a Reissigová $b Jindra $p UIVT-O $i Oddělení statistického modelování $j Department of Statistical Modelling $w Department of Statistical Modelling $T Ústav informatiky AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0035333 $a Černá $b K. $y CZ 701 -1
$3 cav_un_auth*0286044 $a Machková $b N. $y CZ 701 -1
$3 cav_un_auth*0286043 $a Ďuricová $b D. $y CZ 701 -1
$3 cav_un_auth*0214759 $a Kolář $b M. $y CZ 701 -1
$3 cav_un_auth*0457104 $a Vlková $b K. $y CZ 701 -1
$3 cav_un_auth*0311106 $a Čermáková $b L. $y CZ 701 -1
$3 cav_un_auth*0457105 $a Lukáš Jr. $b M. $y CZ 856 $u https://dx.doi.org/10.48095/ccgh2023336 $9 RIV
Number of the records: 1